article thumbnail

How PartnerSlate is Digitizing the Food and Beverage Contract Manufacturing Industry

XTalks

The online marketplace PartnerSlate has made waves in the food and beverage contract manufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contract manufacturers. This is where San Francisco-based PartnerSlate comes in.

article thumbnail

Selkirk Pharma: Adapting to regulatory shifts and market demand

BioPharma Reporter

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing

Pharmaceutical Technology

Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market.

article thumbnail

How a specialized commercial program management team can improve your customer experience and accelerate commercialization 

Pharmaceutical Technology

With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. The Halle customer service team is a “one-stop-shop” for client requests when it comes to commercial drug product manufacturing,” explains Dragitsch.

article thumbnail

Leading clinical dose companies in contract marketing

Pharmaceutical Technology

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular.

Marketing 100
article thumbnail

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). In order to achieve these plans, CAMP 4’s CEO, Josh Mandel-Brehm stated the company will prioritise raising capital through partnerships and business development.

RNA 245
article thumbnail

Gender Pay Gap Worsens Within European Life Sciences Industry

Pharma Marketing Network

Spreads also vary by industry sector with clinical research organizations and contract manufacturing having the lowest gaps at 8 percent with medical device companies at the highest at almost 22 percent with biopharma (pre-commercial) following at nearly 21 percent.